Banreet Dhindsa
Gastroenterology · East Providence, RINPI 1285154666
Payments from drug & device makers
What this record shows
Boston Scientific accounts for 69.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,592 and has fallen 81.2% since, to $299 in 2025. That places this record below the midpoint for gastroenterology clinicians in RI, where the typical reported total is $2,112.
Across 26 payments — averaging $97.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Micro-tech Endoscopy USA, Inc.$291
- Fujifilm Healthcare Americas Corporation$160
- Olympus America Inc.$114
- AbbVie$113
- Medtronic$65
- plus $36 from 1 others
What the payments were for
- Travel & lodging$1,09043%
- Food & beverage$1,45357%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $1,763 |
| Micro-tech Endoscopy USA, Inc. | 2 | $291 |
| Fujifilm Healthcare Americas Corporation | 2 | $160 |
| Olympus America Inc. | 1 | $114 |
| AbbVie | 2 | $113 |
| Medtronic | 1 | $65 |
| Olympus Corporation Of The Americas | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,543 in reported general payments places this provider in the 50th percentile of 85 gastroenterology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 27 | $331 |
| Cefpodoxime Proxetil | 13 | $331 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in East Providence
- May MinEast Providence$663
- Robert BierwirthCranston$603K
- Thomas SepeProvidence$307K
- Morris ElevadoCranston$233K
- Joseph LowneyWarwick$127K
- Paul AkermanProvidence$123K
- Sean FineProvidence$55K
- Breton RousselProvidence$50K
- Alan EpsteinProvidence$36K
- Samir ShahProvidence$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.